Rural Health
Resources by Topic: Substance use and misuse
Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
Evaluates factors associated with geographic remoteness of 60 miles or more from the nearest phase 2 or 3 clinical trial for a variety of health conditions. Discusses American Indian reservations and rural areas, and provides data on demographic factors associated with remoteness including race and ethnicity, educational attainment, and poverty. Includes a county-level interactive map of clinical trial remoteness for health conditions including cancers, substance use disorder, diabetes, obesity, COPD, stroke, and more.
Additional links: Interactive Map
Author(s): Andrew Friedson, Bumyang Kim, Maggie Switek, Lawson Mansell
Date: 06/2024
Type: Document
Sponsoring organization: The Milken Institute
view details
Evaluates factors associated with geographic remoteness of 60 miles or more from the nearest phase 2 or 3 clinical trial for a variety of health conditions. Discusses American Indian reservations and rural areas, and provides data on demographic factors associated with remoteness including race and ethnicity, educational attainment, and poverty. Includes a county-level interactive map of clinical trial remoteness for health conditions including cancers, substance use disorder, diabetes, obesity, COPD, stroke, and more.
Additional links: Interactive Map
Author(s): Andrew Friedson, Bumyang Kim, Maggie Switek, Lawson Mansell
Date: 06/2024
Type: Document
Sponsoring organization: The Milken Institute
view details
Assessing How Alcohol Use Patterns Relate to Obesity among American Adolescents from Rural and Urban Areas: Five Years of Pooled Data
Analyzes the association between alcohol use and obesity among rural and urban adolescents aged 12-17. Utilizes 2015-2019 National Survey on Drug Use and Health data.
Author(s): Christian E. Vazquez, Fawn A. Brown, Faheem Ohri, Philip Baiden
Citation: PLoS ONE, 19(6), e0305638
Date: 06/2024
Type: Document
view details
Analyzes the association between alcohol use and obesity among rural and urban adolescents aged 12-17. Utilizes 2015-2019 National Survey on Drug Use and Health data.
Author(s): Christian E. Vazquez, Fawn A. Brown, Faheem Ohri, Philip Baiden
Citation: PLoS ONE, 19(6), e0305638
Date: 06/2024
Type: Document
view details
Community Buprenorphine Continuation Post-Release Following Extended Release Vs. Sublingual Buprenorphine During Incarceration: A Pilot Project in Maine
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Evaluation of the Vermont All-Payer Accountable Care Organization Model: 2018-2022 - Fourth Evaluation Report
Evaluates the first five performance years of the Vermont All-Payer Accountable Care Organization Model (VTAPM), which aims to assess whether scaling an Accountable Care Organization (ACO) across all payers in the state can reduce program expenditures while preserving or improving care quality. Discusses the implementation of the model, provider engagement, efforts to address population health goals; characteristics of participating hospitals, practitioners, and beneficiaries; and the model's impacts on Medicare spending, utilization, and quality of care. Includes analyses of Medicare ACO subgroups and Medicaid spending, utilization, and quality of care trends. Outlines challenges and lessons learned.
Additional links: Findings at a Glance, Technical Appendices
Date: 06/2024
Type: Document
Sponsoring organizations: Centers for Medicare and Medicaid Services, NORC at the University of Chicago
view details
Evaluates the first five performance years of the Vermont All-Payer Accountable Care Organization Model (VTAPM), which aims to assess whether scaling an Accountable Care Organization (ACO) across all payers in the state can reduce program expenditures while preserving or improving care quality. Discusses the implementation of the model, provider engagement, efforts to address population health goals; characteristics of participating hospitals, practitioners, and beneficiaries; and the model's impacts on Medicare spending, utilization, and quality of care. Includes analyses of Medicare ACO subgroups and Medicaid spending, utilization, and quality of care trends. Outlines challenges and lessons learned.
Additional links: Findings at a Glance, Technical Appendices
Date: 06/2024
Type: Document
Sponsoring organizations: Centers for Medicare and Medicaid Services, NORC at the University of Chicago
view details
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Supporting Direct Acting Antiviral Medication Adherence and Treatment Completion in a Sample of Predominantly Rural Veterans with Hepatitis C and Substance Use Disorders
Explores strategies to improve direct acting antiviral (DAA) treatment among rural veterans with chronic hepatitis C virus (HCV) infection and substance use disorder (SUD). Analyzes a clinic-based intervention that utilizes motivational interviewing (MI) to improve medication adherence among 20 enrolled participants in a 12-week course.
Author(s): Mary Jane Burton, Andrew C. Voluse, Amee B. Patel
Citation: Addiction Science & Clinical Practice, 19, 51
Date: 06/2024
Type: Document
view details
Explores strategies to improve direct acting antiviral (DAA) treatment among rural veterans with chronic hepatitis C virus (HCV) infection and substance use disorder (SUD). Analyzes a clinic-based intervention that utilizes motivational interviewing (MI) to improve medication adherence among 20 enrolled participants in a 12-week course.
Author(s): Mary Jane Burton, Andrew C. Voluse, Amee B. Patel
Citation: Addiction Science & Clinical Practice, 19, 51
Date: 06/2024
Type: Document
view details
Is Peer Support a Tipping Point for the Opioid Use Disorder Crisis in Appalachia? Research Holds the Answer
Investigates how the relationship among cultural, socioeconomic, medical, and geographic factors in Central Appalachia create additional burdens for opioid use recovery. Analyzes the effectiveness of medications for opioid use disorder and peer recovery support services, providing recommendations to address opioid use disorder in Appalachia.
Author(s): Kimberly Horn, Stephanie M. Mathis, Lara Nagle, et al.
Citation: Harm Reduction, 21, 122
Date: 06/2024
Type: Document
view details
Investigates how the relationship among cultural, socioeconomic, medical, and geographic factors in Central Appalachia create additional burdens for opioid use recovery. Analyzes the effectiveness of medications for opioid use disorder and peer recovery support services, providing recommendations to address opioid use disorder in Appalachia.
Author(s): Kimberly Horn, Stephanie M. Mathis, Lara Nagle, et al.
Citation: Harm Reduction, 21, 122
Date: 06/2024
Type: Document
view details
Attitudes Toward and Training in Medications for Opioid Use Disorders: A Descriptive Analysis among Employees in the Youth Legal System and Community Mental Health Centers
Results of a survey of 181 medications for opioid use disorder uptake (MOUD) professionals who work with youth legal system (YLS) and community mental health center (CMHC) settings in eight counties of a Midwestern state. Compares attitudes toward MOUD treatment, training, and workplace culture in rural versus urban areas, among CMHC versus YLS respondents, and more.
Author(s): Lauren M. O'Reilly, Katherine Schwartz, Steven A. Brown, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 32
Date: 06/2024
Type: Document
view details
Results of a survey of 181 medications for opioid use disorder uptake (MOUD) professionals who work with youth legal system (YLS) and community mental health center (CMHC) settings in eight counties of a Midwestern state. Compares attitudes toward MOUD treatment, training, and workplace culture in rural versus urban areas, among CMHC versus YLS respondents, and more.
Author(s): Lauren M. O'Reilly, Katherine Schwartz, Steven A. Brown, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 32
Date: 06/2024
Type: Document
view details
Community Health Needs and Opportunities in Rural Central New York
Reports on community health in central New York's Cayuga, Cortland, Madison, and Oswego counties. Discusses issues related to rural access to care, funding, and health workforce supply. Highlights health disparities affecting rural Black, Hispanic, multiracial, LGBTQ+, and disabled people. Includes sections dedicated to perinatal health, oral health, mental health and substance use, and medical and nonmedical home care.
Date: 06/2024
Type: Document
Sponsoring organization: Health Foundation for Western & Central New York
view details
Reports on community health in central New York's Cayuga, Cortland, Madison, and Oswego counties. Discusses issues related to rural access to care, funding, and health workforce supply. Highlights health disparities affecting rural Black, Hispanic, multiracial, LGBTQ+, and disabled people. Includes sections dedicated to perinatal health, oral health, mental health and substance use, and medical and nonmedical home care.
Date: 06/2024
Type: Document
Sponsoring organization: Health Foundation for Western & Central New York
view details
"I Don't Think That a Medication Is Going to Help Someone Long-Term Stay off Opioids": Treatment and Recovery Beliefs of Rural Vermont Family Members of People with Opioid Use Disorder
Examines beliefs related to opioid use disorder (OUD) treatment and recovery from the perspective of the family members of people with OUD. Analyzes interview data from 20 rural Vermont family members and discusses themes such as medication for OUD (MOUD), OUD treatment and mental health services, patient readiness for OUD treatment, and stigma.
Author(s): Catherine E. Peasley-Miklus, Julia G. Shaw, Katie Rosingana, et al.
Citation: Journal of Rural Health
Date: 06/2024
Type: Document
view details
Examines beliefs related to opioid use disorder (OUD) treatment and recovery from the perspective of the family members of people with OUD. Analyzes interview data from 20 rural Vermont family members and discusses themes such as medication for OUD (MOUD), OUD treatment and mental health services, patient readiness for OUD treatment, and stigma.
Author(s): Catherine E. Peasley-Miklus, Julia G. Shaw, Katie Rosingana, et al.
Citation: Journal of Rural Health
Date: 06/2024
Type: Document
view details